Literature DB >> 16220505

Group sequential, sample size re-estimation and two-stage adaptive designs in clinical trials: a comparison.

Weichung Joe Shih1.   

Abstract

Mesh:

Year:  2006        PMID: 16220505     DOI: 10.1002/sim.2252

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  6 in total

1.  Approaches to handling data when a phase II trial deviates from the pre-specified Simon's two-stage design.

Authors:  Yujun Wu; Weichung J Shih
Journal:  Stat Med       Date:  2008-12-20       Impact factor: 2.373

2.  An insight into the properties of a two-stage design in bioequivalence studies.

Authors:  Vangelis Karalis; Panos Macheras
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

3.  GLUMIP 2.0: SAS/IML Software for Planning Internal Pilots.

Authors:  John A Kairalla; Christopher S Coffey; Keith E Muller
Journal:  J Stat Softw       Date:  2008-11-13       Impact factor: 6.440

4.  Adaptive design clinical trials: Methodology, challenges and prospect.

Authors:  Rajiv Mahajan; Kapil Gupta
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

5.  Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment.

Authors:  Guoqiao Wang; Richard E Kennedy; Gary R Cutter; Lon S Schneider
Journal:  Alzheimers Dement (N Y)       Date:  2015-04-14

Review 6.  Adaptive design methods in clinical trials - a review.

Authors:  Shein-Chung Chow; Mark Chang
Journal:  Orphanet J Rare Dis       Date:  2008-05-02       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.